Position in BMY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$106,539
-$5,602 QoQ
Shares Held
1,849
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,234
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $56,834,770 across 10 Drug Manufacturers - General names. BMY ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
103,992 | $26,410,848 | |
| 2 | NVS |
Novartis AG
|
49,020 | $7,682,414 | |
| 3 | ABBV |
AbbVie Inc.
|
29,986 | $7,545,677 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,965 | $6,549,002 | |
| 5 | AZN |
Astrazeneca PLC
|
32,459 | $6,154,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,077 | $1,291,786 | |
| 7 | AMGN |
Amgen Inc
|
3,003 | $1,087,446 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
1,849 | $106,539 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,539 | 1,849 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $112,141 | 1,849 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $99,735 | 1,849 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $83,389 | 1,849 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $85,590 | 1,849 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $112,770 | 1,849 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $104,579 | 1,849 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $132,920 | 2,569 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $106,690 | 2,569 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $139,316 | 2,569 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $79,273 | 1,545 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $89,671 | 1,545 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $201,122 | 3,145 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $204,117 | 2,945 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $211,892 | 2,945 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $237,796 | 3,345 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $257,565 | 3,345 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $244,285 | 3,345 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $422,421 | 6,775 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,267,076 | 89,016 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,599,143 | 98,760 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,197,156 | 98,165 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,238,046 | 100,565 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,019,353 | 99,840 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $5,616,458 | 95,518 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,304,998 | 95,174 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||